Latest News

Dr. Roy Herbst shares the progress that has been made in lung cancer care and research at Smilow Cancer Hospital and Yale Cancer Center.

An intensive two-day Yale Cancer Research symposium, dedicated to advancing cancer science through innovation and strengthening partnerships between Yale University and Historically Black Colleges and Universities (HBCUs), brought together researchers from multiple disciplines this week.

Yale Cancer Center's Specialized Program of Research Excellence (SPORE) in Lung Cancer has been awarded a renewal grant from the National Cancer Institute (NCI) for year 11 of the program. The prestigious grant, totaling $12M over five years, will provide critical funding to advance groundbreaking lung cancer research and accelerate progress in the prevention, detection, and treatment of this disease.

In honor of National Cancer Research Month, Dr. Katerina Politi shares why her research is focused on cancer.

Yale Cancer Center joined Hill Day, hosted by the American Association for Cancer Research (AACR) and the Association of American Cancer Institutes (AACI) to bring cancer center directors, researchers, physician-scientists, cancer survivors, and other advocates together to build support for a strong federal investment in biomedical research—and cancer research in particular—through the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Hill Day is a special opportunity in that it helps members of cancer centers secure time to meet with their Congressional representatives to share the importance and impact of cancer funding.

Yale Cancer Center faculty and trainees joined 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in Chicago for the 116th American Association for Cancer Research (AACR) annual meeting. Dr. Patricia LoRusso, Amy and Joseph Perella Professor of Medicine at Yale Cancer Center and AACR President for 2024-25, shared her global view on cancer. “Cancer is a global disease—it spares no continent, no country. And each patient that gets the disease deserves treatment.”

Yale Cancer Center presentations at the AACR Annual Meeting will include oral and poster presentations as well as educational sessions, showcasing cutting-edge cancer science and medicine.

Formerly called the Conclave Awards, the 2025 Spring Yale Cancer Center awards honored research, clinical expertise, and support staff at the Hotel Marcel, New Haven on April 1, 2025.

Dr. Roy S. Herbst, MD, PhD received the 2024 Ezra Greenspan Award from The Chemotherapy+ Foundation at a gala in New York Nov. 19, 2024. He is a deputy director of the Yale Cancer Center and Chief of Hematology/Medical Oncology, YCC and Smilow Cancer Hospital; Assistant Dean for Translational Research, Yale School of Medicine; Program Director, Master of Health Science—Clinical Investigation Track (MHS-CI)